Leishmaniasis, Mucocutaneous: Clinical Trials

21 trials for Leishmaniasis, Mucocutaneous, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

11 completed, 5 unknown, 3 recruiting, 1 not yet recruiting. 12 Phase 2, 6 Phase 3, 4 Phase 1, 1 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 212Completed 7, Unknown 4, Recruiting 1
Phase 36Unknown 4, Completed 2
Phase 14Completed 3, Not yet recruiting 1
Not applicable1Completed 1

Follow Leishmaniasis, Mucocutaneous: new trials by email Literature Review of Leishmaniasis, Mucocutaneous trials Research Report on Leishmaniasis, Mucocutaneous

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pilot Study: Miltefosine Gel (G-MTF) in Patients With Cutaneous Leishmaniasis
MILTEFOSINE gel - Cutaneous Leishmaniasis, Cutaneous Leishmaniasis, American
Phase 1Not yet recruitingUniversidad Industrial de Santander152026-01-012025-09-08
Treatment of Bolivian L Braziliensis Mucosal Leishmaniasis With Inhaled Pentamidine Plus Oral Miltefosine
Miltefosine Oral Capsule - Mucosal Leishmaniasis
Phase 2RecruitingFundacion Nacional de Dermatologia302025-02-042025-02-26
LEISH-PED: Study on Leishmaniasis in Children
Leishmania Infantum Disease, Leishmaniasis, Visceral
RecruitingMeyer Children's Hospital IRCCS2002025-01-302026-04-01
Tofacitinib Associated With Meglumine Antimoniate in Cutaneous Leishmaniasis
Oral tofacitinib, Parenteral meglumine antimoniate - Cutaneous Leishmaniasis, American
Phase 2 / Phase 3UnknownHospital Universitário Professor Edgard Santos222023-10-012023-08-25
Pilot Study: Oral Treatment of American Tegumentary Leishmaniasis (Cutaneous and Mucosal Forms) in the Elderly
Miltefosine 50mg, Pentoxifylline 400mg, Liposomal Amphotericin B - Leishmaniasis; Brazilian, Leishmaniasis, Mucocutaneous
Phase 2 / Phase 3UnknownUniversity of Brasilia1002022-06-222023-09-15
Phase 2 Trial to Evaluate 18-Methoxycoronaridine Efficacy, Safety and Tolerability in Cutaneous Leishmaniasis Patients
18-Methoxycoronaridine, Glucantime - Leishmaniasis; American, Cutaneous, Drug Side Effect
Phase 2UnknownInfan Industria Quimica Farmaceutica Nacional522021-05-012020-03-19
Treatment of Mucosal Bolivian Leishmaniasis
Group 1: Miltefosine, Group 2: Pentavalent Antimony, Group 3: Liposomal amphotericin B - Mucosal Leishmaniasis
Phase 3UnknownFundacion Nacional de Dermatologia1202021-04-012024-03-05
Feasibility and Usability of Mobile Applications for Monitoring Cutaneous Leishmaniasis Treatment in Colombia
Community based strategy to follow-up pactientes with Cutaneous Leishmaniasis - Cutaneous Leishmaniasis, American
Not applicableCompletedCentro Internacional de Entrenamiento e Investigaciones Médicas1052020-03-012022-09-09
Treatment of Cutaneous Leishmaniasis With Liposomal Amphotericin B in the Elderly
Liposomal amphotericin B (AmBisome®) - Cutaneous Leishmaniasis, American
Phase 1 / Phase 2CompletedHospital Universitário Professor Edgard Santos282019-03-012024-06-07
Oral Miltefosine Plus Topical Paromomycin In American Cutaneous Leishmaniasis
Miltefosine and Paromomycin, miltefosine, paromomycin - Cutaneous Leishmaniasis, American
Phase 2 / Phase 3CompletedFundacion Nacional de Dermatologia1202019-02-012021-02-02
Topical Sm29 in Combination With Meglumine Antimoniate in the Treatment of Cutaneous Leishmaniasis.
Sm29 Protein, Schistosoma Mansoni, Pentavalent antimony (Sbv) - Cutaneous Leishmaniasis, American
Phase 1 / Phase 2CompletedHospital Universitário Professor Edgard Santos202019-01-172023-08-21
Topical Paromomycin for Cutaneous Leishmaniasis in Bolivia
Paromomycin Sulfate, Pentamidine Isethionate, Placebo - Leishmaniasis, Cutaneous, Leishmania Braziliensis Complex
Phase 2 / Phase 3CompletedFundacion Nacional de Dermatologia802017-04-152021-02-02
Dedicated QT Study in Bolivian Patients Taking Impavido® (Miltefosine) for Mucocutaneous Leishmaniasis
Miltefosine - Mucocutaneous Leishmaniasis
CompletedKnight Therapeutics (USA) Inc422015-12-012020-09-04
Spermiogram Assessment in Bolivian Patients Taking Impavido® (Miltefosine) for Mucocutaneous Leishmaniasis
Miltefosine - Mucocutaneous Leishmaniasis
CompletedKnight Therapeutics (USA) Inc552015-07-012019-03-04
Fourth-generation Immucillin Derivative DI4G Associated Therapy in Cutaneous Leishmaniasis
Immucillin DI4G, Meglumine antimoniate - Leishmaniasis, Leishmaniasis, Cutaneous
Phase 2CompletedHospital Universitário Professor Edgard Santos502014-12-012017-09-26
Miltefosine to Treat Mucocutaneous Leishmaniasis
Miltefosine - Mucosal Leishmaniasis, Cutaneous Leishmaniasis
Phase 2CompletedKnight Therapeutics (USA) Inc42010-05-012020-09-30
Clinical Trial of Miltefosine to Treat Mucosal Leishmaniasis
Miltefosine, Standard Treatment Meglumine antimoniate - Leishmaniasis, Leishmaniasis, Mucocutaneous
Phase 2CompletedBrasilia University Hospital402009-07-012015-06-09
Low Antimonial Dosage in American Mucosal Leishmaniasis
Meglumine antimoniate - Mucosal Leishmaniasis, Mucocutaneous Leishmaniasis
Phase 2 / Phase 3UnknownOswaldo Cruz Foundation762008-10-012018-07-12
Study to Evaluate the Leish-111F + MPL-SE Vaccine in the Treatment of Mucosal Leishmaniasis
Leish-111f + MPL-SE vaccine - Leishmaniasis, Mucocutaneous
Phase 1CompletedAccess to Advanced Health Institute (AAHI)482004-07-012007-02-15
Diagnosis and Treatment of Leishmania Infections
Kinetoplastid, Skin Diseases, Parasitic
RecruitingNational Institute of Allergy and Infectious Diseases (NIAID)4002001-11-302026-10-29

Showing 20 of 21. Sign in to see all of them.

Narrower conditions

Leishmaniasis (10)  ·  Leishmaniasis, Cutaneous (10)  ·  Leishmaniasis, Visceral (2)  ·  Drug-Related Side Effects and Adverse Reactions (1)  ·  Parasitic Diseases (1)  ·  Skin Diseases, Parasitic (1)

Broader conditions

Euglenozoa Infections (21)  ·  Infections (21)  ·  Protozoan Infections (21)  ·  Skin Diseases (21)  ·  Skin Diseases, Infectious (21)  ·  Skin and Connective Tissue Diseases (21)  ·  Vector Borne Diseases (21)  ·  Parasitic Diseases (20)  ·  Skin Diseases, Parasitic (20)  ·  Leishmaniasis (11)  ·  Leishmaniasis, Cutaneous (11)  ·  Chemically-Induced Disorders (1)

Interventions

miltefosine (8)  ·  Meglumine Antimoniate (3)  ·  Paromomycin (2)  ·  liposomal amphotericin B (2)  ·  18-methoxycoronaridine (1)  ·  Antimony Sodium Gluconate (1)  ·  Pentamidine (1)  ·  Pentoxifylline (1)  ·  Sm29 protein, Schistosoma mansoni (1)  ·  tofacitinib (1)

Sponsors

Fundacion Nacional de Dermatologia (4)  ·  Hospital Universitário Professor Edgard Santos (4)  ·  Knight Therapeutics (USA) Inc (3)  ·  Access to Advanced Health Institute (AAHI) (1)  ·  Brasilia University Hospital (1)  ·  Centro Internacional de Entrenamiento e Investigaciones Médicas (1)  ·  Infan Industria Quimica Farmaceutica Nacional (1)  ·  Meyer Children's Hospital IRCCS (1)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (1)  ·  Oswaldo Cruz Foundation (1)  ·  Universidad Industrial de Santander (1)  ·  University of Brasilia (1)  ·  University of California, San Francisco (1)

Countries

Brazil (7)  ·  Bolivia (6)  ·  United States (3)  ·  Colombia (2)  ·  Italy (1)  ·  Peru (1)

Top investigators

Jaime Soto, MD (2)  ·  Alejandro Llanos-Cuentas, MD (1)  ·  Armando O. Schubach, MD, PhD (1)  ·  Brian Schwartz, MD (1)  ·  Cristian Blanco, PhD (1)  ·  Edgar M Carvalho, MD, PhD (1)  ·  Elise M O'Connell, M.D. (1)  ·  Franco M Piazza, MD, MPh (1)  ·  Jonathan Berman, MD (1)  ·  Juliana SF Silva, MD (1)  ·  Kanade Shinkai, MD (1)  ·  Paulo RL Machado, MD, PhD (1)

Results publications

PMID 11353640, PMID 20851080, PMID 27927991, PMID 30260376, PMID 30815688, PMID 36395328, PMID 39147194